Crunching the numbers for WVE... Refresh in a moment for the full analysis.
Wave Life Sciences Ltd. (WVE)
Healthcare
weak
$7.18
Updated: 2026-04-12
34
TradeApes Score
reduce
Financial Strength
25
Stressed
Operating Trend
10
Stressed
Valuation
50
Mixed
Capital Allocation
30
Weak
Risk
80
Strong
Key Findings
+
Strong liquidity — current assets more than 2× current liabilities
−
Sharp revenue decline — sales down more than 15% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.